Friday, June 17, 2016

Merck's Keytruda beats out chemotherapy in phase 3 lung cancer trial

… previously untreated advanced non-small cell lung cancer (NSCLC) whose tumors expressed high … in first-line treatment of non-small-cell lung cancer.
"We look forward to …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)